SCHEMBL2178975

SCHEMBL2178975

CNc1nccc(-c2cc(NCCCN(CCCOC)C(=O)O)c3cc(OC)ccc3c2)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 2/20 0.37
ABL1 P00519 2/20 0.37
BCR P11274 2/20 0.37
HDAC3 O15379 1/20 0.36
NCOR1 O75376 1/20 0.36
HDAC2 Q92769 1/20 0.36
PLA2G2A P14555 2/20 0.36
HTR1A P08908 2/20 0.36
ADRA1D P25100 2/20 0.36
ADRA1A P35348 2/20 0.36
ADRA1B P35368 2/20 0.36
AKT3 Q9Y243 1/20 0.35
ACP1 P24666 1/20 0.35
MKNK1 Q9BUB5 1/20 0.34
NR4A1 P22736 1/20 0.34
PDK1 Q15118 1/20 0.34
EIF2AK2 P19525 2/20 0.34
PIK3CA P42336 1/20 0.34
PIK3CB P42338 1/20 0.34
PIK3CG P48736 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2181723 0.90 ABL1 (0.35) SYKABL1BCRHDAC3NCOR1
SCHEMBL2181726 0.85 SYK (0.34) SYKABL1BCRHDAC3NCOR1
SCHEMBL2177415 0.84 HTR1A (0.40) HTR1AADRA1DADRA1AADRA1BMKNK1
SCHEMBL2678527 0.81 MTNR1A (0.39) HDAC3NCOR1HDAC2HTR1AADRA1D
SCHEMBL2176324 0.81 MKNK1 (0.43) SYKABL1BCRHTR1AADRA1D
SCHEMBL2177838 0.81 FERMT2 (0.44) SYKHDAC3NCOR1HDAC2HTR1A
SCHEMBL2178230 0.81 HTR1A (0.43) HTR1AADRA1DADRA1AADRA1BACP1
SCHEMBL2678111 0.79 MTNR1A (0.40) HDAC3NCOR1HDAC2EIF2AK2PIK3CA
SCHEMBL6128782 0.78 HDAC3 (0.38) HDAC3NCOR1HDAC2MKNK1PIK3CA
SCHEMBL2178808 0.78 CASP2 (0.41) HDAC3NCOR1HDAC2PIK3CAPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173808-B2 Substituted naphthalenyl-pyrimidine compounds ARQULE, INC. (US) 2012-05-08 US claimed
EP-2519519-A2 SUBSTITUTED NAPHTHALENYL-PYRIMIDINE COMPOUNDS ArQule, Inc. (US) 2012-11-07 EP disclosed
US-8173808-B2 Substituted naphthalenyl-pyrimidine compounds ARQULE, INC. (US) 2012-05-08 US disclosed
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds ARQULE, INC. (US) 2011-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds DPYD, TP53, TYMP SYK 3080/4885ABL1 128/4885BCR 694/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.